[English] 日本語
Yorodumi- EMDB-71308: eN49P7-FRv1-23 Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | eN49P7-FRv1-23 Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab | |||||||||
Map data | sharpened map | |||||||||
Sample |
| |||||||||
Keywords | antibody engineering / HIV-1 / bnAb / broadly neutralizing antibody / CD4 binding site / Env / VIRAL PROTEIN | |||||||||
| Function / homology | Function and homology informationsymbiont-mediated perturbation of host defense response / positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell ...symbiont-mediated perturbation of host defense response / positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / membrane / identical protein binding Similarity search - Function | |||||||||
| Biological species | ![]() Human immunodeficiency virus 1 / ![]() Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.7 Å | |||||||||
Authors | Phulera S / Ozorowski G / Ward AB | |||||||||
| Funding support | 1 items
| |||||||||
Citation | Journal: bioRxiv / Year: 2025Title: Engineering HIV antibodies with enhanced breadth and potency of neutralization through multistate affinity maturation. Authors: Mateusz Kędzior / Swastik Phulera / Monica L Fernández-Quintero / Johannes R Loeffler / Collin Joyce / Jordan Woehl / Abdolrahim Abbasi / Maryam Karimi / Arash Aslanabadi / Mahsa Hojabri / ...Authors: Mateusz Kędzior / Swastik Phulera / Monica L Fernández-Quintero / Johannes R Loeffler / Collin Joyce / Jordan Woehl / Abdolrahim Abbasi / Maryam Karimi / Arash Aslanabadi / Mahsa Hojabri / Roza Zareidoodeji / Ben Atkinson / Eduar Fernando Pinzon Burgos / Alonso Heredia / Karen Saye-Francisco / Quoc Tran / Yoojin Kim / Fernando Acosta-Puente / Lara Shahin / Amelia Zhou / Pilar X Altman / Nathaniel R Felbinger / Brian G Pierce / Devin Sok / Michael S Seaman / Dennis R Burton / Anthony L DeVico / Andrew B Ward / Gabriel Ozorowski / Mohammad M Sajadi / Joseph G Jardine / ![]() Abstract: Broadly neutralizing antibodies (bnAbs) against HIV hold promise as therapeutic and prophylactic agents, but realizing this potential requires antibodies that function across the antigenic ...Broadly neutralizing antibodies (bnAbs) against HIV hold promise as therapeutic and prophylactic agents, but realizing this potential requires antibodies that function across the antigenic heterogeneity of the HIV envelope glycoprotein (Env). Although numerous bnAbs have been isolated from infected individuals, their breadth and potency may not be sufficient to tackle global viral diversity, motivating efforts to further improve their neutralization capacity. Here, we address this challenge using a multistate antibody engineering approach integrating deep mutational scanning with combinatorial library screening across diverse Env variants. This strategy enables identification of mutation patterns that confer improved binding across antigenically distinct targets. Starting from one of the best-in-class CD4-binding site bnAbs, we performed iterative optimization to increase binding affinity across diverse Env variants. The resulting lead candidate exhibited improved breadth and up to 100-fold higher potency against pseudoviruses from large cross-clade historical and contemporary panels while maintaining biophysical and pharmacokinetic profiles conducive to clinical development. Structural and molecular dynamics analyses revealed a unique tri-tyrosine aromatic triad and reinforced electrostatic contacts that stabilized the bnAb/Env interface. These findings demonstrate that systematic engineering can generate bnAbs with enhanced breadth and potency, providing a generalizable strategy for developing therapeutic antibodies against highly diverse pathogens. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_71308.map.gz | 230.3 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-71308-v30.xml emd-71308.xml | 24.4 KB 24.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_71308_fsc.xml | 13.1 KB | Display | FSC data file |
| Images | emd_71308.png | 160.7 KB | ||
| Masks | emd_71308_msk_1.map | 244.1 MB | Mask map | |
| Filedesc metadata | emd-71308.cif.gz | 7.5 KB | ||
| Others | emd_71308_half_map_1.map.gz emd_71308_half_map_2.map.gz | 226.5 MB 226.5 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-71308 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-71308 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9p6gMC ![]() 9p6eC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_71308.map.gz / Format: CCP4 / Size: 244.1 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | sharpened map | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.0339 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Mask #1
| File | emd_71308_msk_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: half map A
| File | emd_71308_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | half map A | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: half map B
| File | emd_71308_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | half map B | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : eN49P7-FRv1-23 Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab
| Entire | Name: eN49P7-FRv1-23 Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab |
|---|---|
| Components |
|
-Supramolecule #1: eN49P7-FRv1-23 Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab
| Supramolecule | Name: eN49P7-FRv1-23 Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#6 |
|---|---|
| Source (natural) | Organism: ![]() Human immunodeficiency virus 1 |
-Macromolecule #1: Envelope glycoprotein gp120
| Macromolecule | Name: Envelope glycoprotein gp120 / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() Human immunodeficiency virus 1 |
| Molecular weight | Theoretical: 54.088289 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: AENLWVTVYY GVPVWKDAET TLFCASDAKA YETEKHNVWA THACVPTDPN PQEIHLENVT EEFNMWKNNM VEQMHEDIIS LWDQSLKPC VKLTPLCVTL QCTNVTNNIT DDMRGELKNC SFNMTTELRD KKQKVYSLFY RLDVVQINEN QGNRSNNSNK E YRLINCNT ...String: AENLWVTVYY GVPVWKDAET TLFCASDAKA YETEKHNVWA THACVPTDPN PQEIHLENVT EEFNMWKNNM VEQMHEDIIS LWDQSLKPC VKLTPLCVTL QCTNVTNNIT DDMRGELKNC SFNMTTELRD KKQKVYSLFY RLDVVQINEN QGNRSNNSNK E YRLINCNT SAITQACPKV SFEPIPIHYC APAGFAILKC KDKKFNGTGP CPSVSTVQCT HGIKPVVSTQ LLLNGSLAEE EV IIRSENI TNNAKNILVQ LNTPVQINCT RPNNNTVKSI RIGPGQAFYY TGDIIGDIRQ AHCNVSKATW NETLGKVVKQ LRK HFGNNT IIRFAQSSGG DLEVTTHSFN CGGEFFYCNT SGLFNSTWIS NTSVQGSNST GSNDSITLPC RIKQIINMWQ RIGQ AMYAP PIQGVIRCVS NITGLILTRD GGSTNSTTET FRPGGGDMRD NWRSELYKYK VVKIEPLGVA PTRCKRRVVG RRRRR R UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #2: Envelope glycoprotein gp41
| Macromolecule | Name: Envelope glycoprotein gp41 / type: protein_or_peptide / ID: 2 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() Human immunodeficiency virus 1 |
| Molecular weight | Theoretical: 17.134324 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: AVGIGAVSLG FLGAAGSTMG AASMTLTVQA RNLLSGIVQQ QSNLLRAPEP QQHLLKDTHW GIKQLQARVL AVEHYLRDQQ LLGIWGCSG KLICCTNVPW NSSWSNRNLS EIWDNMTWLQ WDKEISNYTQ IIYGLLEESQ NQQEKNEQDL LALD UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #3: RM20A3 heavy chain
| Macromolecule | Name: RM20A3 heavy chain / type: protein_or_peptide / ID: 3 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 13.511111 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: EVQLVETGGG LVQPGGSLKL SCRASGYTFS SFAMSWVRQA PGKGLEWVSL INDRGGLTFY VDSVKGRFTI SRDNSKNTLS LQMHSLRDG DTAVYYCATG GMSSALQSSK YYFDFWGQGA LVTVSS |
-Macromolecule #4: RM20A3 light chain
| Macromolecule | Name: RM20A3 light chain / type: protein_or_peptide / ID: 4 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 11.540614 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: ALTQPPSVSG SPGQSVTISC TGTSSDIGSY NYVSWYQQHP GKAPKLMIYD VTQRPSGVSD RFSGSKSGNT ASLTISGLQA DDEADYYCS AYAGRQTFYI FGGGTRLTVL |
-Macromolecule #5: eN49P7-FRv1-23 heavy chain
| Macromolecule | Name: eN49P7-FRv1-23 heavy chain / type: protein_or_peptide / ID: 5 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 15.432193 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: ADLVQSGAVT KKPGDSVRIS CEAQGYRFTD YFIHWIRQAP GKGPEWMGWI NPYYGQVNIP WKFQGRISMT RQRSQDPYDP DWGTAFLDL RGLKSDDTAV YYCVRDRSSG YGKLFESDNW FLDLWGRGTA VTIQS |
-Macromolecule #6: eN49P7-FRv1-23 light chain
| Macromolecule | Name: eN49P7-FRv1-23 light chain / type: protein_or_peptide / ID: 6 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 10.855144 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: QSALTQPNYV SALPGQSVTI SCTGTHNLVS WLQHQPGRAP KLLIYDFNKR PPGVPDRFSG SGSGGTASLT ITGLQLDDEA EYWCFAYEV FGGGTKLTVL MQ |
-Macromolecule #10: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 10 / Number of copies: 36 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 5.9 |
|---|---|
| Grid | Model: UltrAuFoil R1.2/1.3 / Material: GOLD / Mesh: 300 / Support film - Material: GOLD / Support film - topology: HOLEY |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | TFS GLACIOS |
|---|---|
| Image recording | Film or detector model: TFS FALCON 4i (4k x 4k) / Average electron dose: 45.0 e/Å2 |
| Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 20.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 1.8 µm / Nominal defocus min: 0.7000000000000001 µm / Nominal magnification: 190000 |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
Movie
Controller
About Yorodumi



Keywords
Human immunodeficiency virus 1
Homo sapiens (human)
Authors
Citation






Z (Sec.)
Y (Row.)
X (Col.)













































Processing
FIELD EMISSION GUN
